CardiologyOnline.net

Cardiology Xagena

Search results for "Antiarrhythmic drugs"

Use of Amiodarone ( Cordarone ), an antiarrhythmic drug, in combination with a beta-blocker is effective in preventing shocks that can occur from an implantable cardioverter defibrillator. The imp ...


Atrial fibrillation ablation is one of the fastest growing techniques in cardiology and due to the very high number of patients that might be candidates to this procedure, a significant number of reso ...


The FDA ( Food and Drug Administration ) has completed a safety review of Multaq ( Dronedarone ). This review showed that Multaq increased the risk of serious cardiovascular events, including death, w ...


Among patients with untreated paroxysmal atrial fibrillation, treatment with radiofrequency ablation resulted in a lower rate of abnormal atrial rhythms and episodes of atrial fibrillation.Arial fibri ...


Before initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of atrial fibrillation is recommended. ( Class I; Level of Evidence: C ) The following antiarrhythmic ...


Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent rec ...


Atrial fibrillation is the most common rhythm disorder seen in clinical practice. Antiarrhythmic drugs are effective for reduction of recurrence in patients with symptomatic paroxysmal atrial fibrilla ...


In final draft guidance NICE ( National Institute for Health and Care Excellence ) has defined which heart devices ( known as implantable cardiac devices ) are the most clinically and cost effective. ...


The American Association for Thoracic Surgery ( AATS ) has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial fibrillation ( POAF ) and f ...


Antiarrhythmic drugs ( AADs ) and anticoagulation are mainstays of atrial fibrillation ( AF ) treatment. A study has assessed the use and outcomes of antiarrhythmic therapy in anticoagulated patients ...


Symptoms are a major driver for patients with atrial fibrillation to seek medical attention and are important to titrate atrial fibrillation therapies. However, a large proportion of patients with atr ...


Little is known in clinical practice about antiarrhythmic drugs ( AADs ) use in patients with atrial fibrillation ( particularly younger ones ) who do not have structural heart disease. Using the ...


Dronedarone ( Multaq ) is a benzofuran derivative with a pharmacological profile similar to Amiodarone but has a more rapid onset of action and a much shorter half-life ( 13-19 h ). Researchers ha ...


Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation frequently recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent r ...


The purpose of the study was to describe the associated baseline features of atrial fibrillation patients with heart failure ( HF ) with reduced and preserved ejection fraction ( HFrEF and HFpEF ). ...